Procter & Gamble (Health & Beauty Care) Ltd.

The Heights, Brooklands, Weybridge, Surrey, KT13 0XP, UK
Telephone: +44 (0)191 297 5000
Fax: +44 (0)191 297 6295
WWW: http://www.uk.pg.com
Customer Care direct line: +44 (0) 8000 850367 (UK)
Customer Care direct line: +353 (1) 800 509 301 (Ireland)


Summary of Product Characteristics last updated on the eMC: 01/06/2011
SPC Regulan Orange Flavour


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Orange Flavour Regulan.


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Orange Flavour Regulan contains 3.4g of Ispaghula Husk, BP.


Go to top of the page
3. PHARMACEUTICAL FORM

Premeasured, single-dose sachets containing an orange flavoured beige, fine ground powder, which when reconstituted with water is intended for administration as an oral solution.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the relief of constipation and for patients who need to increase their daily fibre intake.


Go to top of the page
4.2 Posology and method of administration

The measured dosage should be poured into a glass and 150ml (¼ pint) of cool water, milk, fruit juice or other liquid added, stirred, and taken immediately. Additional liquid may be taken if required. Adequate fluid intake should be maintained.

Adults and children over 12 years

Usual dosage is the entire contents of one sachet taken one to three times daily.

Elderly

No alteration in dosage necessary.

Children 6-12 years

A reduced dosage based upon age of the child should be given. ½ - 1 level teaspoonful one to three times daily.


Go to top of the page
4.3 Contraindications

Not to be given to patients with intestinal obstruction, faecal impaction, colonic atony or hypersensitivity to ispaghula or any of the ingredients.

Do not give to children under 6 years of age, unless on the advice of a doctor


Go to top of the page
4.4 Special warnings and precautions for use

It is important to take the product with sufficient fluid

Orange Flavour Regulan should always be taken as a liquid suspension and should be drunk immediately after mixing. The last dose should not be taken immediately before going to sleep since impaired or reduced gastric motility may impair the intestinal passage and then cause sub-obstruction. The drug may cause allergic reactions in people sensitive to inhaled or ingested ispaghula powder.

It may be advisable to supervise treatment in the elderly or debilitated and patients with intestinal narrowing or decreased motility, as rare instances of gastrointestinal obstruction have been reported with mucilloid preparations when taken, contrary to the administration instructions, with insufficient liquid.

Each sachet contains 26mg of phenylalanine and this should be considered in phenylketonuric patients.

The colouring agent, Sunset Yellow, can cause allergic type reactions including asthma. Allergy is more common in those people who are allergic to aspirin.

If symptoms persist consult your doctor

Keep out of reach and sight of children.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

There are no known clinical relevant interactions


Go to top of the page
4.6 Pregnancy and lactation

Controlled studies in pregnant and lactating women are not available, but the product has been in wide use for many years without apparent ill consequence and animal studies have shown no hazard. Ispaghula is not thought to be absorbed nor is it thought to enter breast milk. Nevertheless the benefits of therapy should be weighed against the possible risks if used during pregnancy and lactation.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

Gastrointestinal disorders:

Regulan (Ispaghula), as with other bulk laxatives, may temporarily increase flatulence and abdominal distension when the product is first used. Other symptoms including nausea, diarrhoea and abdominal discomfort or pain have rarely been reported (<1 in 1000).

Intestinal obstruction and faecal impaction may occur very rarely (<1 in 10,000), especially if the product is taken with insufficient fluid.

Immune system disorders:

There are very rare reports (<1 in 10,000) of allergic or hypersensitivity reactions associated with the ingestion or inhalation of Ispaghula including skin rashes or allergic dermatitis, rhinitis, urticaria, bronchospasm and anaphylactic reactions.


Go to top of the page
4.9 Overdose

No instances of true overdosage have been reported. If overdosage should occur there is no specific treatment and symptomatic measures should be employed.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

The active constituent, ispaghula husk, is the epidermis and collapsed adjacent layers removed from the dried ripe seeds of plantago ovata, containing mucilage and hemicelluloses.

The ispaghula husk is not absorbed and produces its effect as a bulking agent by physical means alone.


Go to top of the page
5.2 Pharmacokinetic properties

Not applicable.


Go to top of the page
5.3 Preclinical safety data

None


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Contains maltodextrin, citric acid, orange flavour, aspartame (E951), and Sunset Yellow FCF (E110). Orange flavour Regulan is sugar free and gluten free. Each sachet contains 0.23 mmol of sodium.


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

Three years.


Go to top of the page
6.4 Special precautions for storage

Store in a dry place not above 25°C.


Go to top of the page
6.5 Nature and contents of container

Paper / aluminium foil / polyethylene sachets. The product is available in packs of 30 sachets.


Go to top of the page
6.6 Special precautions for disposal and other handling

A patient leaflet is provided with details of use and handling of the product.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Procter & Gamble (Health & Beauty Care) Limited

The Heights, Brooklands,

Weybridge,

Surrey, KT13 0XP

UK


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 0129/0114


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

15 September 1992


Go to top of the page
10. DATE OF REVISION OF THE TEXT

01/08/2009



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/3854/SPC/


Active Ingredients/Generics

 
   ispaghula husk